Product NDC: | 0517-0901 |
Proprietary Name: | Hydralazine Hydrochloride |
Non Proprietary Name: | Hydralazine Hydrochloride |
Active Ingredient(s): | 20 mg/mL & nbsp; Hydralazine Hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0517-0901 |
Labeler Name: | American Regent, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040136 |
Marketing Category: | ANDA |
Start Marketing Date: | 19970630 |
Package NDC: | 0517-0901-25 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-0901-25) > 1 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0517-0901-25 |
Proprietary Name | Hydralazine Hydrochloride |
Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-0901-25) > 1 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0517-0901 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydralazine Hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19970630 |
Marketing Category Name | ANDA |
Labeler Name | American Regent, Inc. |
Substance Name | HYDRALAZINE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC] |